Ann: Invitation to Investor Briefing, page-8

Pretty quiet on these threads but any investor in ACW or those interested should get along to 1 of these investor briefings taking place across the country. Just need to look at what IMC did yesterday at 1 point up 100% to see the potential gains that could be presenting for ACW as they progress phs2 trials. The Alzheimer's space presents a huge market need where majors are struggling to find new breakthroughs and ACW may well unlock a new way of treating the disease. I believe the majors will be watching ACW very closely in particular Pfizer with MD Bill Ketelbey ex Pfizer leading the way here. Bios have long been quiet but the IMC move yesterday suggests there is still interest and more coming into the sector.